Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study ; day:23 ; month:2 ; year:2023 ; pages:1-11
Archives of dermatological research ; (23.2.2023), 1-11

Creator
Schoot, L. S. van der
Verhoef, L. M.
Ee, I. van
Oort, F. P. A. H. van
Pieterse, A. H.
Seyger, M. M. B.
Jong, E. M. G. J. de
den Reek, J. M. P. A. van
Contributor
SpringerLink (Online service)

DOI
10.1007/s00403-023-02566-w
URN
urn:nbn:de:101:1-2023052013472596475450
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Schoot, L. S. van der
  • Verhoef, L. M.
  • Ee, I. van
  • Oort, F. P. A. H. van
  • Pieterse, A. H.
  • Seyger, M. M. B.
  • Jong, E. M. G. J. de
  • den Reek, J. M. P. A. van
  • SpringerLink (Online service)

Other Objects (12)

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities

Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities

Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies

Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies

Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review

Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review

Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review

Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review

The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables

The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables

Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis

Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis

Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy

Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy

Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study

Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study

Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis

Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis

Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study

Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study

Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry

Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry

Related objects